<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36507225</PMID><DateRevised><Year>2022</Year><Month>12</Month><Day>22</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2589-0042</ISSN><JournalIssue CitedMedium="Internet"><Volume>26</Volume><Issue>1</Issue><PubDate><Year>2023</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>iScience</Title><ISOAbbreviation>iScience</ISOAbbreviation></Journal><ArticleTitle>A multi-omics based anti-inflammatory immune signature characterizes long COVID-19 syndrome.</ArticleTitle><Pagination><StartPage>105717</StartPage><MedlinePgn>105717</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">105717</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.isci.2022.105717</ELocationID><Abstract><AbstractText>To investigate long COVID-19 syndrome (LCS) pathophysiology, we performed an exploratory study with blood plasma derived from three groups: 1) healthy vaccinated individuals without SARS-CoV-2 exposure; 2) asymptomatic recovered patients at least three months after SARS-CoV-2 infection and; 3) symptomatic patients at least 3&#xa0;months after SARS-CoV-2 infection with chronic fatigue syndrome or similar symptoms, here designated as patients with long COVID-19 syndrome (LCS). Multiplex cytokine profiling indicated slightly elevated pro-inflammatory cytokine levels in recovered individuals in contrast to patients with LCS. Plasma proteomics demonstrated low levels of acute phase proteins and macrophage-derived secreted proteins in LCS. High levels of anti-inflammatory oxylipins including omega-3 fatty acids in LCS were detected by eicosadomics, whereas targeted metabolic profiling indicated high levels of anti-inflammatory osmolytes taurine and hypaphorine, but low amino acid and triglyceride levels and deregulated acylcarnitines. A model considering alternatively polarized macrophages as a major contributor to these molecular alterations is presented.</AbstractText><CopyrightInformation>&#xa9; 2022 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kovarik</LastName><ForeName>Johannes J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna 1090, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bileck</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Joint Metabolome Facility, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagn</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meier-Menches</LastName><ForeName>Samuel M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Joint Metabolome Facility, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frey</LastName><ForeName>Tobias</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaempf</LastName><ForeName>Anna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hollenstein</LastName><ForeName>Marlene</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shoumariyeh</LastName><ForeName>Tarik</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Internal Medicine III, Clinical Division of Nephrology and Dialysis, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna 1090, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Skos</LastName><ForeName>Lukas</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reiter</LastName><ForeName>Birgit</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerner</LastName><ForeName>Marlene C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Division of Biomedical Science, University of Applied Sciences FH Campus Wien, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Spannbauer</LastName><ForeName>Andreas</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hasimbegovic</LastName><ForeName>Ena</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmidl</LastName><ForeName>Doreen</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garh&#xf6;fer</LastName><ForeName>Gerhard</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Clinical Pharmacology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gy&#xf6;ngy&#xf6;si</LastName><ForeName>Mariann</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medicine II, Division of Cardiology, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schmetterer</LastName><ForeName>Klaus G</ForeName><Initials>KG</Initials><AffiliationInfo><Affiliation>Department of Laboratory Medicine, Medical University of Vienna, Waehringer G&#xfc;rtel 18-20, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gerner</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Joint Metabolome Facility, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Waehringer Stra&#xdf;e 38, 1090 Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>iScience</MedlineTA><NlmUniqueID>101724038</NlmUniqueID><ISSNLinking>2589-0042</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immunology</Keyword><Keyword MajorTopicYN="N">immune response</Keyword><Keyword MajorTopicYN="N">omics</Keyword></KeywordList><CoiStatement>The authors CG, KS, SMM, JK, AB and MG have filed a patent application to the European Patent Office with the application number EP22176741 (date June 1st. 2022) and the title:&#x201d; METHODS AND MEANS FOR MOLECULAR CHARACTERIZATION OF POST-VIRAL FATIGUE SYNDROME.&#x201d; The other authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>11</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>13</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>12</Day><Hour>11</Hour><Minute>32</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36507225</ArticleId><ArticleId IdType="pmc">PMC9719844</ArticleId><ArticleId IdType="doi">10.1016/j.isci.2022.105717</ArticleId><ArticleId IdType="pii">S2589-0042(22)01990-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>de la Rica R., Borges M., Gonzalez-Freire M. COVID-19: in the eye of the cytokine storm. Front. Immunol. 2020;11:558898. doi: 10.3389/fimmu.2020.558898.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.558898</ArticleId><ArticleId IdType="pmc">PMC7541915</ArticleId><ArticleId IdType="pubmed">33072097</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovarik J.J., K&#xe4;mpf A.K., Gasser F., Herdina A.N., Breuer M., Kaltenecker C.C., Wahrmann M., Haindl S., Mayer F., Traby L., et al. Identification of immune activation markers in the early onset of COVID-19 infection. Front. Cell. Infect. Microbiol. 2021;11:651484. doi: 10.3389/fcimb.2021.651484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2021.651484</ArticleId><ArticleId IdType="pmc">PMC8446609</ArticleId><ArticleId IdType="pubmed">34540715</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K., Rogers A.J., McAuley D.F. Delving beneath the surface of hyperinflammation in COVID-19. Lancet. Rheumatol. 2020;2:e578&#x2013;e579. doi: 10.1016/S2665-9913(20)30304-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2665-9913(20)30304-0</ArticleId><ArticleId IdType="pmc">PMC7442423</ArticleId><ArticleId IdType="pubmed">32864626</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 "long haulers" stump experts. JAMA. 2020;324:1381&#x2013;1383. doi: 10.1001/jama.2020.17709.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17709</ArticleId><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect. Dis. 2021;53:737&#x2013;754. doi: 10.1080/23744235.2021.1924397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Blomberg B., Mohn K.G.I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.A., Lartey S., Onyango T.B., Kuwelker K., S&#xe6;vik M., et al. Long COVID in a prospective cohort of home-isolated patients. Nat. Med. 2021;27:1607&#x2013;1613. doi: 10.1038/s41591-021-01433-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01433-3</ArticleId><ArticleId IdType="pmc">PMC8440190</ArticleId><ArticleId IdType="pubmed">34163090</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah R., Ali F.M., Nixon S.J., Ingram J.R., Salek S.M., Finlay A.Y. Measuring the impact of COVID-19 on the quality of life of the survivors, partners and family members: a cross-sectional international online survey. BMJ Open. 2021;11:e047680. doi: 10.1136/bmjopen-2020-047680.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-047680</ArticleId><ArticleId IdType="pmc">PMC8154981</ArticleId><ArticleId IdType="pubmed">34035105</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed H., Patel K., Greenwood D.C., Halpin S., Lewthwaite P., Salawu A., Eyre L., Breen A., O'Connor R., Jones A., Sivan M. Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J.&#xa0;Rehabil. Med. 2020;52:jrm00063. doi: 10.2340/16501977-2694.</Citation><ArticleIdList><ArticleId IdType="doi">10.2340/16501977-2694</ArticleId><ArticleId IdType="pubmed">32449782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cervia C., Zurbuchen Y., Taeschler P., Ballouz T., Menges D., Hasler S., Adamo S., Raeber M.E., B&#xe4;chli E., Rudiger A., et al. Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome. Nat. Commun. 2022;13:446. doi: 10.1038/s41467-021-27797-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27797-1</ArticleId><ArticleId IdType="pmc">PMC8789854</ArticleId><ArticleId IdType="pubmed">35078982</ArticleId></ArticleIdList></Reference><Reference><Citation>From the American Association of Neurological Surgeons. American Society of Neuroradiology. Cardiovascular and Interventional Radiology Society of Europe. Canadian Interventional Radiology Association. Congress of Neurological Surgeons. European Society of Minimally Invasive Neurological Therapy. European Society of Neuroradiology. European Stroke Organization. Society for Cardiovascular Angiography and Interventions. Society of Interventional Radiology. Society of NeuroInterventional Surgery. World Stroke Organization. Sacks D., Baxter B., Campbell B.C.V., Carpenter J.S., Cognard C., Dippel D., Eesa M., Fischer U., Hausegger K., Hirsch J.A., et al. Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int. J. Stroke. 2018;13:612&#x2013;632. doi: 10.1177/1747493018778713.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493018778713</ArticleId><ArticleId IdType="pubmed">29786478</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y., Yuan D., Chen D.G., Ng R.H., Wang K., Choi J., Li S., Hong S., Zhang R., Xie J., et al. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185:881&#x2013;895.e20. doi: 10.1016/j.cell.2022.01.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.01.014</ArticleId><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Muqaku B., Pils D., Mader J.C., Aust S., Mangold A., Muqaku L., Slany A., Del Favero G., Gerner C. Neutrophil extracellular trap formation correlates with favorable overall survival in high grade ovarian cancer. Cancers. 2020;12:505. doi: 10.3390/cancers12020505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12020505</ArticleId><ArticleId IdType="pmc">PMC7072166</ArticleId><ArticleId IdType="pubmed">32098278</ArticleId></ArticleIdList></Reference><Reference><Citation>Reichl B., Niederstaetter L., Boegl T., Neuditschko B., Bileck A., Gojo J., Buchberger W., Peyrl A., Gerner C. Determination of a tumor-promoting microenvironment in recurrent medulloblastoma: a multi-omics study of cerebrospinal fluid. Cancers. 2020;12:1350. doi: 10.3390/cancers12061350.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12061350</ArticleId><ArticleId IdType="pmc">PMC7352284</ArticleId><ArticleId IdType="pubmed">32466393</ArticleId></ArticleIdList></Reference><Reference><Citation>Muqaku B., Eisinger M., Meier S.M., Tahir A., Pukrop T., Haferkamp S., Slany A., Reichle A., Gerner C. Multi-omics analysis of serum samples demonstrates reprogramming of organ functions via systemic calcium mobilization and platelet activation in metastatic melanoma. Mol. Cell. Proteomics. 2017;16:86&#x2013;99. doi: 10.1074/mcp.M116.063313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.M116.063313</ArticleId><ArticleId IdType="pmc">PMC5217785</ArticleId><ArticleId IdType="pubmed">27879288</ArticleId></ArticleIdList></Reference><Reference><Citation>Franzke B., Bileck A., Unterberger S., Aschauer R., Z&#xf6;hrer P.A., Draxler A., Strasser E.M., Wessner B., Gerner C., Wagner K.H. The plasma proteome is favorably modified by a high protein diet but not by additional resistance training in older adults: a 17-week randomized controlled trial. Front. Nutr. 2022;9:925450. doi: 10.3389/fnut.2022.925450.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2022.925450</ArticleId><ArticleId IdType="pmc">PMC9389340</ArticleId><ArticleId IdType="pubmed">35990326</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis E.A., Norris P.C. Eicosanoid storm in infection and inflammation. Nat. Rev. Immunol. 2015;15:511&#x2013;523. doi: 10.1038/nri3859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri3859</ArticleId><ArticleId IdType="pmc">PMC4606863</ArticleId><ArticleId IdType="pubmed">26139350</ArticleId></ArticleIdList></Reference><Reference><Citation>Leitner G.C., Hagn G., Niederstaetter L., Bileck A., Plessl-Walder K., Horvath M., Kolovratova V., Tanzmann A., Tolios A., Rabitsch W., et al. INTERCEPT pathogen reduction in platelet concentrates, in contrast to gamma irradiation, induces the formation of trans-arachidonic acids and affects eicosanoid release during storage. Biomolecules. 2022;12:1258. doi: 10.3390/biom12091258.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12091258</ArticleId><ArticleId IdType="pmc">PMC9496540</ArticleId><ArticleId IdType="pubmed">36139096</ArticleId></ArticleIdList></Reference><Reference><Citation>Altmann R., Hausmann M., Sp&#xf6;ttl T., Gruber M., Bull A.W., Menzel K., Vogl D., Herfarth H., Sch&#xf6;lmerich J., Falk W., Rogler G. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells. Biochem. Pharmacol. 2007;74:612&#x2013;622. doi: 10.1016/j.bcp.2007.05.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bcp.2007.05.027</ArticleId><ArticleId IdType="pubmed">17604003</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain A., Ruppert D., Levine S.M., Hanson M.R. Metabolic profiling of a myalgic encephalomyelitis/chronic fatigue syndrome discovery cohort reveals disturbances in fatty acid and lipid metabolism. Mol. Biosyst. 2017;13:371&#x2013;379. doi: 10.1039/c6mb00600k.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/c6mb00600k</ArticleId><ArticleId IdType="pmc">PMC5365380</ArticleId><ArticleId IdType="pubmed">28059425</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun H., Zhu X., Cai W., Qiu L. Hypaphorine attenuates lipopolysaccharide-induced endothelial inflammation via regulation of TLR4 and PPAR-gamma dependent on PI3K/Akt/mTOR signal pathway. Int. J. Mol. Sci. 2017;18:844. doi: 10.3390/ijms18040844.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms18040844</ArticleId><ArticleId IdType="pmc">PMC5412428</ArticleId><ArticleId IdType="pubmed">28420166</ArticleId></ArticleIdList></Reference><Reference><Citation>Ozawa M., Honda K., Nakai I., Kishida A., Ohsaki A. Hypaphorine, an indole alkaloid from Erythrina velutina, induced sleep on normal mice. Bioorg. Med. Chem. Lett. 2008;18:3992&#x2013;3994. doi: 10.1016/j.bmcl.2008.06.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bmcl.2008.06.002</ArticleId><ArticleId IdType="pubmed">18571406</ArticleId></ArticleIdList></Reference><Reference><Citation>Atri C., Guerfali F.Z., Laouini D. Role of human macrophage polarization in inflammation during infectious diseases. Int. J. Mol. Sci. 2018;19:1801. doi: 10.3390/ijms19061801.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19061801</ArticleId><ArticleId IdType="pmc">PMC6032107</ArticleId><ArticleId IdType="pubmed">29921749</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardoso A.P., Pinto M.L., Castro F., Costa &#xc2;.M., Marques-Magalh&#xe3;es &#xc2;., Canha-Borges A., Cruz T., Velho S., Oliveira M.J. The immunosuppressive and pro-tumor functions of CCL18 at the tumor microenvironment. Cytokine Growth Factor Rev. 2021;60:107&#x2013;119. doi: 10.1016/j.cytogfr.2021.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cytogfr.2021.03.005</ArticleId><ArticleId IdType="pubmed">33863622</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon M.Y., Park E., Lee S.J., Chung S.W. Heme oxygenase-1 accelerates erastin-induced ferroptotic cell death. Oncotarget. 2015;6:24393&#x2013;24403. doi: 10.18632/oncotarget.5162.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/oncotarget.5162</ArticleId><ArticleId IdType="pmc">PMC4695193</ArticleId><ArticleId IdType="pubmed">26405158</ArticleId></ArticleIdList></Reference><Reference><Citation>Toro A., Ruiz M.S., Lage-Vickers S., Sanchis P., Sabater A., Pascual G., Seniuk R., Cascardo F., Ledesma-Bazan S., Vilicich F., et al. A journey into the clinical relevance of heme oxygenase 1 for human inflammatory disease and viral clearance: why does it matter on the COVID-19 scene? Antioxidants. 2022;11:276. doi: 10.3390/antiox11020276.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antiox11020276</ArticleId><ArticleId IdType="pmc">PMC8868141</ArticleId><ArticleId IdType="pubmed">35204159</ArticleId></ArticleIdList></Reference><Reference><Citation>Bestle D., Heindl M.R., Limburg H., Van Lam van T., Pilgram O., Moulton H., Stein D.A., Hardes K., Eickmann M., Dolnik O., et al. TMPRSS2 and furin are both essential for proteolytic activation of SARS-CoV-2 in human airway cells. Life Sci. Alliance. 2020;3 doi: 10.26508/lsa.202000786. e202000786.</Citation><ArticleIdList><ArticleId IdType="doi">10.26508/lsa.202000786</ArticleId><ArticleId IdType="pmc">PMC7383062</ArticleId><ArticleId IdType="pubmed">32703818</ArticleId></ArticleIdList></Reference><Reference><Citation>Hiki N., Berger D., Prigl C., Boelke E., Wiedeck H., Seidelmann M., Staib L., Kaminishi M., Oohara T., Beger H.G. Endotoxin binding and elimination by monocytes: secretion of soluble CD14 represents an inducible mechanism counteracting reduced expression of membrane CD14 in patients with sepsis and in a patient with paroxysmal nocturnal hemoglobinuria. Infect. Immun. 1998;66:1135&#x2013;1141. doi: 10.1128/IAI.66.3.1135-1141.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.66.3.1135-1141.1998</ArticleId><ArticleId IdType="pmc">PMC108026</ArticleId><ArticleId IdType="pubmed">9488406</ArticleId></ArticleIdList></Reference><Reference><Citation>Noschka R., Gerbl F., L&#xf6;ffler F., Kubis J., Rodr&#xed;guez A.A., Mayer D., Grieshober M., Holch A., Raasholm M., Forssmann W.G., et al. Unbiased identification of angiogenin as an endogenous antimicrobial protein with activity against virulent Mycobacterium tuberculosis. Front. Microbiol. 2020;11:618278. doi: 10.3389/fmicb.2020.618278.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2020.618278</ArticleId><ArticleId IdType="pmc">PMC7848861</ArticleId><ArticleId IdType="pubmed">33537017</ArticleId></ArticleIdList></Reference><Reference><Citation>Das N., Schmidt T.A., Krawetz R.J., Dufour A. Proteoglycan 4: from mere lubricant to regulator of tissue homeostasis and inflammation: does proteoglycan 4 have the ability to buffer the inflammatory response? Bioessays. 2019;41:e1800166. doi: 10.1002/bies.201800166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/bies.201800166</ArticleId><ArticleId IdType="pubmed">30485469</ArticleId></ArticleIdList></Reference><Reference><Citation>Qadri M., Jay G.D., Zhang L.X., Schmidt T.A., Totonchy J., Elsaid K.A. Proteoglycan-4 is an essential regulator of synovial macrophage polarization and inflammatory macrophage joint infiltration. Arthritis Res. Ther. 2021;23:241. doi: 10.1186/s13075-021-02621-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02621-9</ArticleId><ArticleId IdType="pmc">PMC8439011</ArticleId><ArticleId IdType="pubmed">34521469</ArticleId></ArticleIdList></Reference><Reference><Citation>Akgun A., Sen A., Onal H. Clinical, biochemical and genotypical characteristics in biotinidase deficiency. J.&#xa0;Pediatr. Endocrinol. Metab. 2021;34:1425&#x2013;1433. doi: 10.1515/jpem-2021-0242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/jpem-2021-0242</ArticleId><ArticleId IdType="pubmed">34448386</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto N., Homma S. Vitamin D3 binding protein (group-specific component) is a precursor for the macrophage-activating signal factor from lysophosphatidylcholine-treated lymphocytes. Proc. Natl. Acad. Sci. USA. 1991;88:8539&#x2013;8543. doi: 10.1073/pnas.88.19.8539.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.19.8539</ArticleId><ArticleId IdType="pmc">PMC52544</ArticleId><ArticleId IdType="pubmed">1924312</ArticleId></ArticleIdList></Reference><Reference><Citation>Lurier E.B., Dalton D., Dampier W., Raman P., Nassiri S., Ferraro N.M., Rajagopalan R., Sarmady M., Spiller K.L. Transcriptome analysis of IL-10-stimulated (M2c) macrophages by next-generation sequencing. Immunobiology. 2017;222:847&#x2013;856. doi: 10.1016/j.imbio.2017.02.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.imbio.2017.02.006</ArticleId><ArticleId IdType="pmc">PMC5719494</ArticleId><ArticleId IdType="pubmed">28318799</ArticleId></ArticleIdList></Reference><Reference><Citation>Caron J.P., Gandy J.C., Brown J.L., Sordillo L.M. Docosahexaenoic acid-derived oxidized lipid metabolites modulate the inflammatory response of lipolysaccharide-stimulated macrophages. Prostaglandins Other Lipid Mediat. 2018;136:76&#x2013;83. doi: 10.1016/j.prostaglandins.2018.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prostaglandins.2018.05.006</ArticleId><ArticleId IdType="pubmed">29763660</ArticleId></ArticleIdList></Reference><Reference><Citation>Dyall S.C. Long-chain omega-3 fatty acids and the brain: a review of the independent and shared effects of EPA, DPA and DHA. Front. Aging Neurosci. 2015;7:52. doi: 10.3389/fnagi.2015.00052.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00052</ArticleId><ArticleId IdType="pmc">PMC4404917</ArticleId><ArticleId IdType="pubmed">25954194</ArticleId></ArticleIdList></Reference><Reference><Citation>Stanley W.C., Khairallah R.J., Dabkowski E.R. Update on lipids and mitochondrial function: impact of dietary n-3 polyunsaturated fatty acids. Curr. Opin. Clin. Nutr. Metab. Care. 2012;15:122&#x2013;126. doi: 10.1097/MCO.0b013e32834fdaf7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MCO.0b013e32834fdaf7</ArticleId><ArticleId IdType="pmc">PMC4067133</ArticleId><ArticleId IdType="pubmed">22248591</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun G.Y., Geng X., Teng T., Yang B., Appenteng M.K., Greenlief C.M., Lee J.C. Dynamic role of phospholipases A2 in health and diseases in the central nervous system. Cells. 2021;10:2963. doi: 10.3390/cells10112963.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10112963</ArticleId><ArticleId IdType="pmc">PMC8616333</ArticleId><ArticleId IdType="pubmed">34831185</ArticleId></ArticleIdList></Reference><Reference><Citation>Marcinkiewicz J., Kontny E. Taurine and inflammatory diseases. Amino Acids. 2014;46:7&#x2013;20. doi: 10.1007/s00726-012-1361-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00726-012-1361-4</ArticleId><ArticleId IdType="pmc">PMC3894431</ArticleId><ArticleId IdType="pubmed">22810731</ArticleId></ArticleIdList></Reference><Reference><Citation>Piotrowicz K., G&#x105;sowski J., Michel J.P., Veronese N. Post-COVID-19 acute sarcopenia: physiopathology and management. Aging Clin. Exp. Res. 2021;33:2887&#x2013;2898. doi: 10.1007/s40520-021-01942-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-021-01942-8</ArticleId><ArticleId IdType="pmc">PMC8323089</ArticleId><ArticleId IdType="pubmed">34328636</ArticleId></ArticleIdList></Reference><Reference><Citation>Khetarpal S.A., Vitali C., Levin M.G., Klarin D., Park J., Pampana A., Millar J.S., Kuwano T., Sugasini D., Subbaiah P.V., et al. Endothelial lipase mediates efficient lipolysis of triglyceride-rich lipoproteins. PLoS Genet. 2021;17:e1009802. doi: 10.1371/journal.pgen.1009802.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pgen.1009802</ArticleId><ArticleId IdType="pmc">PMC8483387</ArticleId><ArticleId IdType="pubmed">34543263</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun S.M., Park J.Y., Seo S.W., Song J. Association of plasma endothelial lipase levels on cognitive impairment. BMC Psychiatr. 2019;19:187. doi: 10.1186/s12888-019-2174-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-019-2174-8</ArticleId><ArticleId IdType="pmc">PMC6585097</ArticleId><ArticleId IdType="pubmed">31216999</ArticleId></ArticleIdList></Reference><Reference><Citation>Naviaux R.K., Naviaux J.C., Li K., Bright A.T., Alaynick W.A., Wang L., Baxter A., Nathan N., Anderson W., Gordon E. Metabolic features of chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2016;113:E5472&#x2013;E5480. doi: 10.1073/pnas.1607571113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1607571113</ArticleId><ArticleId IdType="pmc">PMC5027464</ArticleId><ArticleId IdType="pubmed">27573827</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Misra A. Post COVID-19 syndrome ("Long COVID") and diabetes: challenges in diagnosis and management. Diabetes Metab. Syndr. 2021;15:102235. doi: 10.1016/j.dsx.2021.102235.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Siska P.J., Decking S.M., Babl N., Matos C., Bruss C., Singer K., Klitzke J., Sch&#xf6;n M., Simeth J., K&#xf6;stler J., et al. Metabolic imbalance of T&#xa0;cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone. J.&#xa0;Clin. Invest. 2021;131:e148225. doi: 10.1172/JCI148225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI148225</ArticleId><ArticleId IdType="pmc">PMC8592546</ArticleId><ArticleId IdType="pubmed">34779418</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.M., Shin E.C. Type I and III interferon responses in SARS-CoV-2 infection. Exp. Mol. Med. 2021;53:750&#x2013;760. doi: 10.1038/s12276-021-00592-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-021-00592-0</ArticleId><ArticleId IdType="pmc">PMC8099704</ArticleId><ArticleId IdType="pubmed">33953323</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui K.P.Y., Cheung M.C., Perera R.A.P.M., Ng K.C., Bui C.H.T., Ho J.C.W., Ng M.M.T., Kuok D.I.T., Shih K.C., Tsao S.W., et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir. Med. 2020;8:687&#x2013;695. doi: 10.1016/S2213-2600(20)30193-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30193-4</ArticleId><ArticleId IdType="pmc">PMC7252187</ArticleId><ArticleId IdType="pubmed">32386571</ArticleId></ArticleIdList></Reference><Reference><Citation>Grant R.A., Morales-Nebreda L., Markov N.S., Swaminathan S., Querrey M., Guzman E.R., Abbott D.A., Donnelly H.K., Donayre A., Goldberg I.A., et al. Circuits between infected macrophages and T&#xa0;cells in SARS-CoV-2 pneumonia. Nature. 2021;590:635&#x2013;641. doi: 10.1038/s41586-020-03148-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-03148-w</ArticleId><ArticleId IdType="pmc">PMC7987233</ArticleId><ArticleId IdType="pubmed">33429418</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhivaki D., Kagan J.C. Innate immune detection of lipid oxidation as a threat assessment strategy. Nat. Rev. Immunol. 2022;22:322&#x2013;330. doi: 10.1038/s41577-021-00618-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00618-8</ArticleId><ArticleId IdType="pmc">PMC8454293</ArticleId><ArticleId IdType="pubmed">34548649</ArticleId></ArticleIdList></Reference><Reference><Citation>Gundacker N.C., Haudek V.J., Wimmer H., Slany A., Griss J., Bochkov V., Zielinski C., Wagner O., St&#xf6;ckl J., Gerner C. Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells. J.&#xa0;Proteome Res. 2009;8:2799&#x2013;2811. doi: 10.1021/pr8011039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/pr8011039</ArticleId><ArticleId IdType="pubmed">19351150</ArticleId></ArticleIdList></Reference><Reference><Citation>Suuring M., Moreau A. Regulatory macrophages and tolerogenic dendritic cells in myeloid regulatory cell-based therapies. Int. J. Mol. Sci. 2021;22:7970. doi: 10.3390/ijms22157970.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22157970</ArticleId><ArticleId IdType="pmc">PMC8348814</ArticleId><ArticleId IdType="pubmed">34360736</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhong S., Li L., Shen X., Li Q., Xu W., Wang X., Tao Y., Yin H. An update on lipid oxidation and inflammation in cardiovascular diseases. Free Radic. Biol. Med. 2019;144:266&#x2013;278. doi: 10.1016/j.freeradbiomed.2019.03.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2019.03.036</ArticleId><ArticleId IdType="pubmed">30946962</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrivastava R., Shukla N. Attributes of alternatively activated (M2) macrophages. Life Sci. 2019;224:222&#x2013;231. doi: 10.1016/j.lfs.2019.03.062.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2019.03.062</ArticleId><ArticleId IdType="pubmed">30928403</ArticleId></ArticleIdList></Reference><Reference><Citation>Naito Y., Takagi T., Higashimura Y. Heme oxygenase-1 and anti-inflammatory M2 macrophages. Arch. Biochem. Biophys. 2014;564:83&#x2013;88. doi: 10.1016/j.abb.2014.09.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.abb.2014.09.005</ArticleId><ArticleId IdType="pubmed">25241054</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P., Casari G., Townsend L., O'Farrelly C., Tancevski I., L&#xf6;ffler-Ragg J., Mogensen T.H., Casanova J.L., COVID Human Genetic Effort Studying severe long COVID to understand post-infectious disorders beyond COVID-19. Nat. Med. 2022;28:879&#x2013;882. doi: 10.1038/s41591-022-01766-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01766-7</ArticleId><ArticleId IdType="pubmed">35383311</ArticleId></ArticleIdList></Reference><Reference><Citation>Zougman A., Selby P.J., Banks R.E. Suspension trapping (STrap) sample preparation method for bottom-up proteomics analysis. Proteomics. 2014;14:1006. doi: 10.1002/pmic.201300553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/pmic.201300553</ArticleId><ArticleId IdType="pubmed">24678027</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J., Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367&#x2013;1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J., Mann M. 1D and 2D annotation enrichment: a statistical method integrating quantitative proteomics with complementary high-throughput data. BMC Bioinf. 2012;13:S12. doi: 10.1186/1471-2105-13-S16-S12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-13-S16-S12</ArticleId><ArticleId IdType="pmc">PMC3489530</ArticleId><ArticleId IdType="pubmed">23176165</ArticleId></ArticleIdList></Reference><Reference><Citation>Fahy E., Sud M., Cotter D., Subramaniam S. LIPID MAPS online tools for lipid research. Nucleic Acids Res. 2007;35:W606&#x2013;W612. doi: 10.1093/nar/gkm324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkm324</ArticleId><ArticleId IdType="pmc">PMC1933166</ArticleId><ArticleId IdType="pubmed">17584797</ArticleId></ArticleIdList></Reference><Reference><Citation>Humphrey S.J., Karayel O., James D.E., Mann M. High-throughput and high-sensitivity phosphoproteomics with the EasyPhos platform. Nat. Protoc. 2018;13:1897&#x2013;1916. doi: 10.1038/s41596-018-0014-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41596-018-0014-9</ArticleId><ArticleId IdType="pubmed">30190555</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>